CClinicalTrials.gg
CompletedNCT00184184Updated Mar 14, 2017

Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients

An observational study in Substance Abuse and Tobacco Use Disorder, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-03-14.

Sponsored by Norwegian University of Science and Technology · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
262
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This is a study of the registration of tobacco, coffee and substance abuse among acutely admitted psychiatric patients.

Read the detailed description

We will include all patients acutely admitted to Østmarka Psychiatric Hospital to register this population's use of coffee, tobacco and substances. We will determine whether this differs from other populations, between diagnoses, age, etc.

We will also compare results of substance in immunologic rapid urine tests taken by the nurse at the hospital with substance in urine tested in laboratory with LC/MS (liquid chromatography/mass spectrometry).

02

Conditions studied

  • Substance Abuse
  • Tobacco Use Disorder

Keywords

  • Emergency Services, Psychiatric
  • Tobacco use cessation
  • Coffee use cessation
  • substance use detection
  • Substance Abuse Detection
03

In context

Substance-Related Disorders

2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.

This study's enrollment of 262 is close to the median of 250 across 296 observational studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All patients acutely admitted to Østmarka Psychiatric Hospital

Exclusion criteria

Exclusion Criteria:

  • Dementia
  • Serious brain damage
05

Study design

Time perspective
Prospective
Enrollment
262 participants (actual)
06

Study locations

1 site
  • Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim
    Trondheim, Norway
07

References and documents

Publications

  • Bagoien G, Morken G, Zahlsen K, Aamo T, Spigset O. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit. J Clin Psychopharmacol. 2009 Jun;29(3):248-54. doi: 10.1097/JCP.0b013e3181a45e78. PubMed 19440078 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 14, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00184184
Lead sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital
Responsible party
Sponsor
First posted
Sep 16, 2005
Start date
Oct 2004
Primary completion
Jun 2005
Completion
Jun 2005
Last update
Mar 14, 2017

Study contacts

Gunnar Morken, MD, PhD
principal investigator · Norwegian ministry of Education and Research
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion